Filing Details

Accession Number:
0000919574-18-002746
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-29 17:07:06
Reporting Period:
2016-01-27
Accepted Time:
2018-03-29 17:07:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1211583 Fennec Pharmaceuticals Inc. FENC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1169253 Manchester Management Co Llc 3 West Hill Place
Boston MA 02114
No No Yes No
1411524 Manchester Explorer, L.p. 3 West Hill Place
Boston MA 02114
No No Yes No
1512127 E James Besser C/O Manchester Management Pr, Llc
53 Palmeras St, Caribe Plz Bld, 6Th Fl
San Juan PR 00901
No No Yes No
1593072 C. Morgan Frank 3 West Hill Place
Boston MA 02114
No No Yes No
1735534 Manchester Management Pr, Llc 53 Palmeras Street
Caribe Plaza Building, 6Th Floor
San Juan PR 00901
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-02-28 8,000 $2.66 2,168,782 No 4 P Indirect See footnote
Common Stock Acquisiton 2017-02-28 8,000 $2.66 1,642,899 No 4 P Direct
Common Stock Acquisiton 2017-03-27 2,000 $2.68 2,170,782 No 4 P Indirect See footnote
Common Stock Acquisiton 2017-03-27 2,000 $2.68 1,644,899 No 4 P Direct
Common Stock Acquisiton 2017-03-30 700 $2.80 2,171,482 No 4 P Indirect See footnote
Common Stock Acquisiton 2017-03-30 700 $2.80 1,645,599 No 4 P Direct
Common Stock Acquisiton 2017-03-31 2,000 $2.97 2,173,482 No 4 P Indirect See footnote
Common Stock Acquisiton 2017-03-31 2,000 $2.97 1,647,599 No 4 P Direct
Common Stock Acquisiton 2017-03-31 2,400 $3.03 2,175,882 No 4 P Indirect See footnote
Common Stock Acquisiton 2017-03-31 2,400 $3.03 1,649,999 No 4 P Direct
Common Stock Acquisiton 2017-04-04 600 $3.39 2,176,482 No 4 P Indirect See footnote
Common Stock Acquisiton 2017-04-04 600 $3.39 1,650,599 No 4 P Direct
Common Stock Acquisiton 2017-04-05 600 $3.45 2,177,082 No 4 P Indirect See footnote
Common Stock Acquisiton 2017-04-05 600 $3.45 1,651,199 No 4 P Direct
Common Stock Disposition 2017-04-12 200 $3.45 2,176,882 No 4 S Indirect See footnote
Common Stock Disposition 2017-04-12 200 $3.45 1,650,999 No 4 S Direct
Common Stock Acquisiton 2017-04-13 100 $4.38 2,176,982 No 4 P Indirect See footnote
Common Stock Acquisiton 2017-04-13 100 $4.38 1,651,099 No 4 P Direct
Common Stock Acquisiton 2017-04-17 200 $4.04 2,177,182 No 4 P Indirect See footnote
Common Stock Acquisiton 2017-04-17 200 $4.04 1,651,299 No 4 P Direct
Common Stock Acquisiton 2017-10-18 20,015 $10.46 2,197,197 No 4 P Indirect See footnote
Common Stock Acquisiton 2017-10-18 20,015 $10.46 1,671,314 No 4 P Direct
Common Stock Acquisiton 2017-10-19 1,300 $10.52 2,198,497 No 4 P Indirect See footnote
Common Stock Acquisiton 2017-10-19 1,300 $10.52 1,672,614 No 4 P Direct
Common Stock Acquisiton 2017-10-24 2,000 $10.23 2,200,497 No 4 P Indirect See footnote
Common Stock Acquisiton 2017-10-24 2,000 $10.23 1,674,614 No 4 P Direct
Common Stock Disposition 2018-02-28 26,000 $9.26 166,666 No 4 S Direct
Common Stock Disposition 2018-02-28 17,100 $9.41 2,183,397 No 4 S Indirect See footnote
Common Stock Disposition 2018-03-02 20,000 $9.17 2,163,397 No 4 S Indirect See footnote
Common Stock Disposition 2018-03-06 6,600 $9.11 2,156,797 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
No 4 P Direct
No 4 P Indirect See footnote
No 4 P Direct
No 4 P Indirect See footnote
No 4 P Direct
No 4 P Indirect See footnote
No 4 P Direct
No 4 P Indirect See footnote
No 4 P Direct
No 4 P Indirect See footnote
No 4 P Direct
No 4 P Indirect See footnote
No 4 P Direct
No 4 S Indirect See footnote
No 4 S Direct
No 4 P Indirect See footnote
No 4 P Direct
No 4 P Indirect See footnote
No 4 P Direct
No 4 P Indirect See footnote
No 4 P Direct
No 4 P Indirect See footnote
No 4 P Direct
No 4 P Indirect See footnote
No 4 P Direct
No 4 S Direct
No 4 S Indirect See footnote
No 4 S Indirect See footnote
No 4 S Indirect See footnote
Footnotes
  1. Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC.
  2. Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
  3. The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership.
  4. The reported securities are directly owned by James E. Besser in his personal capacity.